{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:24:59Z","timestamp":1787214299090,"version":"build-2736575974"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Thematic Research Agency in Health and Life Sciences, Algeria"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"DOI":"10.1007\/s11481-026-10313-x","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T06:56:41Z","timestamp":1787209001000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Crosslink Between Neuroinflammation and Oxidative\/Nitrosative Status in the Glioblastoma Tumor Microenvironment: Prognostic and Theranostic Impact"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9939-4366","authenticated-orcid":false,"given":"Narimene","family":"Beder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9561-2226","authenticated-orcid":false,"given":"Mourad","family":"Belkhelfa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8940-4783","authenticated-orcid":false,"given":"Lynda","family":"Hassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0091-8818","authenticated-orcid":false,"given":"Yamina","family":"Yousfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Adel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5289-4614","authenticated-orcid":false,"given":"Toufik","family":"Selmane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6073-0692","authenticated-orcid":false,"given":"Souhil","family":"Tliba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"10313_CR1","doi-asserted-by":"crossref","unstructured":"Aebi H (1984) Catalase in vitro. Methods in enzymology, vol vol 105. Academic Press, p pp 121-126","DOI":"10.1016\/S0076-6879(84)05016-3"},{"key":"10313_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1564572","volume":"15","author":"H Akk\u0131z","year":"2025","unstructured":"Akk\u0131z H, \u015eim\u015fek H, Balc\u0131 D, \u00dclger Y, Onan E, Ak\u00e7aer N, Delik A (2025) Inflammation and cancer: molecular mechanisms and clinical consequences. Front Oncol 15:1564572","journal-title":"Front Oncol"},{"key":"10313_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.680021","volume":"12","author":"MS Alghamri","year":"2021","unstructured":"Alghamri MS, McClellan BL, Hartlage CS, Haase S, Faisal SM, Thalla R, Castro MG (2021) Targeting neuroinflammation in brain cancer: uncovering mechanisms, pharmacological targets, and neuropharmaceutical developments. Front Pharmacol 12:680021","journal-title":"Front Pharmacol"},{"key":"10313_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.584626","volume":"11","author":"F Antonangeli","year":"2020","unstructured":"Antonangeli F, Natalini A, Garassino MC, Sica A, Santoni A, Di Rosa F (2020) Regulation of PD-L1 Expression by NF-\u03baB in cancer. [Research Support, Non-U S Gov\u2019t Review]. Front Immunol 11:584626","journal-title":"Front Immunol"},{"key":"10313_CR5","doi-asserted-by":"publisher","first-page":"1002294","DOI":"10.37349\/etat.2025.1002294","volume":"6","author":"N Beder","year":"2025","unstructured":"Beder N, Mirbahari SN, Belkhelfa M, Mahdizadeh H, Totonchi M (2025) Unmasking the potential: mechanisms of neuroinflammatory modulation by oncolytic viruses in glioblastoma. [Review]. Explor Target Antitumor Ther 6:1002294","journal-title":"Explor Target Antitumor Ther"},{"issue":"12","key":"10313_CR6","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1523\/JNEUROSCI.0156-06.2006","volume":"26","author":"A Belmadani","year":"2006","unstructured":"Belmadani A, Tran PB, Ren D, Miller RJ (2006) Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J Neurosci 26(12):3182\u20133191","journal-title":"J Neurosci"},{"issue":"7","key":"10313_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071783","volume":"10","author":"A Carrano","year":"2021","unstructured":"Carrano A, Juarez JJ, Incontri D, Ibarra A, Guerrero Cazares H (2021) Sex-specific differences in glioblastoma. Cells 10(7):1783","journal-title":"Cells"},{"issue":"22","key":"10313_CR8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163802","volume":"133","author":"Z Chen","year":"2023","unstructured":"Chen Z, Giotti B, Kaluzova M, Vallcorba MP, Rawat K, Price G, Hambardzumyan D (2023) A paracrine circuit of IL-1\u03b2\/IL-1R1 between myeloid and tumor cells drives genotype-dependent glioblastoma progression. J Clin Invest 133(22):e163802","journal-title":"J Clin Invest"},{"key":"10313_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2023.215049","volume":"481","author":"Z Chu","year":"2023","unstructured":"Chu Z, Yang J, Zheng W, Sun J, Wang W, Qian H (2023) Recent advances on modulation of H2O2 in tumor microenvironment for enhanced cancer therapeutic efficacy. Coord Chem Rev 481:215049. https:\/\/doi.org\/10.1016\/j.ccr.2023.215049","journal-title":"Coord Chem Rev"},{"issue":"3","key":"10313_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41591-018-0337-7","volume":"25","author":"TF Cloughesy","year":"2019","unstructured":"Cloughesy TF, Mochizuki AY, Orpilla JR, Hugo W, Lee AH, Davidson TB, Prins RM (2019) Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nat Med 25(3):477\u2013486. https:\/\/doi.org\/10.1038\/s41591-018-0337-7","journal-title":"Nat Med"},{"key":"10313_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2021.103231","volume":"77","author":"R Dharmajaya","year":"2022","unstructured":"Dharmajaya R, Sari DK (2022) Malondialdehyde value as radical oxidative marker and endogenous antioxidant value analysis in brain tumor. Ann Med Surg 77:103231","journal-title":"Ann Med Surg"},{"issue":"1","key":"10313_CR12","doi-asserted-by":"publisher","first-page":"024","DOI":"10.1186\/s12987-024-00590-0","volume":"21","author":"S Digiovanni","year":"2024","unstructured":"Digiovanni S, Lorenzati M, Bianciotto OT, Godel M, Fontana S, Akman M, Salaroglio IC (2024) Blood-brain barrier permeability increases with the differentiation of glioblastoma cells in vitro. Fluids Barriers CNS 21(1):024\u201300590","journal-title":"Fluids Barriers CNS"},{"issue":"44","key":"10313_CR13","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1038\/onc.2011.615","volume":"31","author":"A Fassl","year":"2012","unstructured":"Fassl A, Tagscherer KE, Richter J, Berriel Diaz M, Alcantara Llaguno SR, Campos B, Roth W (2012) Notch1 signaling promotes survival of glioblastoma cells via EGFR-mediated induction of anti-apoptotic Mcl-1. Oncogene 31(44):4698\u20134708. https:\/\/doi.org\/10.1038\/onc.2011.615","journal-title":"Oncogene"},{"issue":"103404","key":"10313_CR14","first-page":"19","volume":"77","author":"C Glorieux","year":"2024","unstructured":"Glorieux C, Buc Calderon P (2024) Targeting catalase in cancer. [Research Support, Non-U S Gov\u2019t Review]. Redox Biol 77(103404):19","journal-title":"Redox Biol"},{"key":"10313_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2020.104996","volume":"69","author":"LF Grilo","year":"2020","unstructured":"Grilo LF, Martins JD, Cavallaro CH, Nathanielsz PW, Oliveira PJ, Pereira SP (2020) Development of a 96-well based assay for kinetic determination of catalase enzymatic-activity in biological samples. Toxicol in Vitro 69:104996. https:\/\/doi.org\/10.1016\/j.tiv.2020.104996","journal-title":"Toxicol in Vitro"},{"issue":"5","key":"10313_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.pjnns.2017.06.011","volume":"51","author":"C Grochowski","year":"2017","unstructured":"Grochowski C, Sta\u015bkiewicz G (2017) Ultra high field TOF-MRA: a method to visualize small cerebral vessels. 7T TOF-MRA sequence parameters on different MRI scanners - literature review. Neurol Neurochir Pol 51(5):411\u2013418. https:\/\/doi.org\/10.1016\/j.pjnns.2017.06.011","journal-title":"Neurol Neurochir Pol"},{"issue":"1","key":"10313_CR17","doi-asserted-by":"publisher","first-page":"bpae015","DOI":"10.1093\/biomethods\/bpae015","volume":"9","author":"MH Hadwan","year":"2024","unstructured":"Hadwan MH, Hussein MJ, Mohammed RM, Hadwan AM, Saad Al-Kawaz H, Al-Obaidy SSM, Al Talebi ZA (2024) An improved method for measuring catalase activity in biological samples. Biol Methods Protoc 9(1):bpae015","journal-title":"Biol Methods Protoc"},{"issue":"3","key":"10313_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11060-009-9973-6","volume":"96","author":"SJ Han","year":"2010","unstructured":"Han SJ, Yang I, Tihan T, Prados MD, Parsa AT (2010) Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity. J Neurooncol 96(3):313\u2013320","journal-title":"J Neurooncol"},{"key":"10313_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.846674","volume":"12","author":"B Hassel","year":"2022","unstructured":"Hassel B, Niehusmann P, Halvorsen B, Dahlberg D (2022) Pro-inflammatory cytokines in cystic glioblastoma: a quantitative study with a comparison with bacterial brain abscesses. With an MRI investigation of displacement and destruction of the brain tissue surrounding a glioblastoma. Front Oncol 12:846674","journal-title":"Front Oncol"},{"issue":"22","key":"10313_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216206","volume":"24","author":"P Jarmuzek","year":"2023","unstructured":"Jarmuzek P, Defort P, Kot M, Wawrzyniak-Gramacka E, Morawin B, Zembron-Lacny A (2023) Cytokine profile in development of glioblastoma in relation to healthy individuals. Int J Mol Sci 24(22):16206","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10313_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2990.1991.tb00713.x","volume":"17","author":"H Jones","year":"1991","unstructured":"Jones H, Steart PV, Weller RO (1991) Spindle-cell glioblastoma or gliosarcoma?. [Comparative Study]. Neuropathol Appl Neurobiol 17(3):177\u2013187","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"13","key":"10313_CR22","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1245\/s10434-015-4518-z","volume":"22","author":"EY Kim","year":"2015","unstructured":"Kim EY, Lee JW, Yoo HM, Park CH, Song KY (2015) The platelet-to-lymphocyte ratio versus neutrophil-to-lymphocyte ratio: which is better as a prognostic factor in gastric cancer? Ann Surg Oncol 22(13):4363\u20134370","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10313_CR23","doi-asserted-by":"publisher","first-page":"802","DOI":"10.7150\/jca.104759","volume":"16","author":"S Kim","year":"2025","unstructured":"Kim S, Kim KH, Jung HW, Jeong EO, Lee HJ, Kwon J, Kim SH (2025) Elevated serum IL-6 as a negative prognostic biomarker in glioblastoma: integrating bioinformatics and clinical validation. J Cancer 16(3):802\u2013811","journal-title":"J Cancer"},{"issue":"1","key":"10313_CR24","doi-asserted-by":"publisher","first-page":"24955","DOI":"10.1038\/s41598-024-76826-8","volume":"14","author":"M Kirishima","year":"2024","unstructured":"Kirishima M, Yokoyama S, Akahane T, Higa N, Uchida H, Yonezawa H, Tanimoto A (2024a) Prognosis prediction via histological evaluation of cellular heterogeneity in glioblastoma. Sci Rep 14(1):24955. https:\/\/doi.org\/10.1038\/s41598-024-76826-8","journal-title":"Sci Rep"},{"issue":"1","key":"10313_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-76826-8","volume":"14","author":"M Kirishima","year":"2024","unstructured":"Kirishima M, Yokoyama S, Akahane T, Higa N, Uchida H, Yonezawa H, Tanimoto A (2024b) Prognosis prediction via histological evaluation of cellular heterogeneity in glioblastoma. Sci Rep 14(1):024-76826","journal-title":"Sci Rep"},{"issue":"6","key":"10313_CR26","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1215\/15228517-2008-123","volume":"11","author":"KR Kozak","year":"2009","unstructured":"Kozak KR, Moody JS (2009) Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis. Neuro-Oncol 11(6):833\u2013841. https:\/\/doi.org\/10.1215\/15228517-2008-123","journal-title":"Neuro-Oncol"},{"issue":"8","key":"10313_CR27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/jnen\/59.8.679","volume":"59","author":"JM Kros","year":"2000","unstructured":"Kros JM, Waarsenburg N, Hayes DP, Hop WC, van Dekken H (2000) Cytogenetic analysis of gemistocytic cells in gliomas. J Neuropathol Exp Neurol 59(8):679\u2013686","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"10313_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13010083","volume":"13","author":"D La Torre","year":"2023","unstructured":"La Torre D, Della Torre A, Lo Turco E, Longo P, Pugliese D, Lacroce P, Tomasello F (2023) Primary intracranial gliosarcoma: is it really a variant of glioblastoma? An update of the clinical, radiological, and biomolecular characteristics. J Clin Med 13(1):83","journal-title":"J Clin Med"},{"issue":"12","key":"10313_CR29","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1158\/1078-0432.CCR-18-2402","volume":"25","author":"JB Lamano","year":"2019","unstructured":"Lamano JB, Li YD, DiDomenico JD, Choy W, Veliceasa D, Oyon DE, Bloch O (2019) Glioblastoma-derived IL6 induces immunosuppressive peripheral myeloid cell PD-L1 and promotes tumor growth. Clin Cancer Res 25(12):3643\u20133657","journal-title":"Clin Cancer Res"},{"key":"10313_CR30","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.2147\/CMAR.S305025","volume":"13","author":"J Li","year":"2021","unstructured":"Li J, Zhou X, Xiang Y, Zhang S, Feng W, Yuan Y, Yin S (2021) Clinical significance of preoperative fibrinogen to albumin ratio in patients with glioblastoma: a singe center experience. Cancer Manag Res 13:3259\u20133269","journal-title":"Cancer Manag Res"},{"issue":"21","key":"10313_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20215347","volume":"20","author":"J Litak","year":"2019","unstructured":"Litak J, Mazurek M, Grochowski C, Kamieniak P, Roli\u0144ski J (2019) The PD-L1\/PD-1 axis in glioblastoma multiforme. Int J Mol Sci 20(21):5347. https:\/\/doi.org\/10.3390\/ijms20215347","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10313_CR32","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803\u2013820","journal-title":"Acta Neuropathol"},{"key":"10313_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107403","volume":"93","author":"A Maghrouni","year":"2021","unstructured":"Maghrouni A, Givari M, Jalili-Nik M, Mollazadeh H, Bibak B, Sadeghi MM, Sahebkar A (2021) Targeting the PD-1\/PD-L1 pathway in glioblastoma multiforme: preclinical evidence and clinical interventions. Int Immunopharmacol 93:107403. https:\/\/doi.org\/10.1016\/j.intimp.2021.107403","journal-title":"Int Immunopharmacol"},{"key":"10313_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.105172","volume":"150","author":"M Mazurek","year":"2021","unstructured":"Mazurek M, Rola R (2021) The implications of nitric oxide metabolism in the treatment of glial tumors. Neurochem Int 150:105172. https:\/\/doi.org\/10.1016\/j.neuint.2021.105172","journal-title":"Neurochem Int"},{"issue":"2","key":"10313_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s11060-012-0895-3","volume":"109","author":"JS Nelson","year":"2012","unstructured":"Nelson JS, Burchfiel CM, Fekedulegn D, Andrew ME (2012) Potential risk factors for incident glioblastoma multiforme: the Honolulu Heart Program and Honolulu-Asia aging study. J Neurooncol 109(2):315\u2013321","journal-title":"J Neurooncol"},{"issue":"8","key":"10313_CR36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2317343121","volume":"121","author":"EK Noch","year":"2024","unstructured":"Noch EK, Palma L, Yim I, Bullen N, Barnett D, Walsh A, Cantley LC (2024) Cysteine induces mitochondrial reductive stress in glioblastoma through hydrogen peroxide production. Proc Natl Acad Sci U S A 121(8):e2317343121","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10313_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14091121","volume":"14","author":"A Nowacka","year":"2025","unstructured":"Nowacka A, \u015aniegocki M, Zi\u00f3\u0142kowska E (2025) Oxidative stress and antioxidants in glioblastoma: mechanisms of action, therapeutic effects and future directions. Antioxidants (Basel) 14(9):1121","journal-title":"Antioxidants (Basel)"},{"issue":"Suppl 5","key":"10313_CR38","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","volume":"24","author":"QT Ostrom","year":"2022","unstructured":"Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS (2022) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015\u20132019. [Research Support, Non-U S Gov\u2019t Research Support, U S Gov\u2019t, P H S]. Neuro Oncol 24(Suppl 5):v1\u2013v95","journal-title":"Neuro Oncol"},{"issue":"6","key":"10313_CR39","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1158\/1078-0432.Ccr-10-2563","volume":"17","author":"RM Prins","year":"2011","unstructured":"Prins RM, Soto H, Konkankit V, Odesa SK, Eskin A, Yong WH, Liau LM (2011) Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. Clin Cancer Res 17(6):1603\u20131615. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-10-2563","journal-title":"Clin Cancer Res"},{"key":"10313_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02241-8","author":"T Pu","year":"2025","unstructured":"Pu T, Sun J, Ren G, Li H (2025) Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-025-02241-8","journal-title":"Signal Transduct Target Ther"},{"issue":"16","key":"10313_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26167883","volume":"26","author":"V Ramar","year":"2025","unstructured":"Ramar V, Guo S, Wang G, Liu M (2025) The pivotal role of NF-\u03baB in glioblastoma: mechanisms of activation and therapeutic implications. Int J Mol Sci 26(16):7883","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10313_CR42","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/cei.13668","volume":"206","author":"R Roesler","year":"2021","unstructured":"Roesler R, Dini SA, Isolan GR (2021) Neuroinflammation and immunoregulation in glioblastoma and brain metastases: Recent developments in imaging approaches. [Research Support, Non-U S Gov\u2019t Review]. Clin Exp Immunol 206(3):314\u2013324","journal-title":"Clin Exp Immunol"},{"key":"10313_CR43","doi-asserted-by":"publisher","first-page":"1183465","DOI":"10.3389\/fimmu.2023.1183465","volume":"14","author":"DS Rubenich","year":"2023","unstructured":"Rubenich DS, de Souza PO, Omizzollo N, Aubin MR, Basso PJ, Silva LM, Braganhol E (2023) Tumor-neutrophil crosstalk promotes in vitro and in vivo glioblastoma progression. [Research Support, Non-U S Gov\u2019t]. Front Immunol 14:1183465","journal-title":"Front Immunol"},{"key":"10313_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bas.2022.101692","volume":"2","author":"M Sae-Huang","year":"2022","unstructured":"Sae-Huang M, Smith LC, Usher I, Hill CS (2022) Cystic glioblastoma: a systematic review and meta-analysis of characteristics and outcomes. Brain Spine 2:101692","journal-title":"Brain Spine"},{"key":"10313_CR45","doi-asserted-by":"crossref","unstructured":"Sahin F, Yildiz P (2015) Serum platelet, MPV, PCT and PDW values, neutrophil to lymphocyte and platelet to lymphocyte ratios in lung cancer diagnosis: European Respiratory Society","DOI":"10.1183\/13993003.congress-2015.PA4279"},{"issue":"3","key":"10313_CR46","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3390\/nu14030666","volume":"14","author":"K Said Abasse","year":"2022","unstructured":"Said Abasse K, Essien EE, Abbas M, Yu X, Xie W, Sun J, Cote A (2022) Association between dietary nitrate, nitrite intake, and site-specific cancer risk: a systematic review and meta-analysis. [Meta-Analysis Systematic Review]. Nutrients 14(3):666","journal-title":"Nutrients"},{"issue":"45","key":"10313_CR47","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3238\/arztebl.2010.0799","volume":"107","author":"T Schneider","year":"2010","unstructured":"Schneider T, Mawrin C, Scherlach C, Skalej M, Firsching R (2010) Gliomas in adults. Gliomas in adults. Dtsch Arztebl Int 107(45):799\u2013807. https:\/\/doi.org\/10.3238\/arztebl.2010.0799","journal-title":"Gliomas in adults. Dtsch Arztebl Int"},{"issue":"4","key":"10313_CR48","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ccell.2017.02.018","volume":"31","author":"JD Schoenfeld","year":"2017","unstructured":"Schoenfeld JD, Sibenaller ZA, Mapuskar KA, Wagner BA, Cramer-Morales KL, Furqan M, Allen BG (2017) O(2)(\u22c5-) and H(2)O(2)-mediated disruption of fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate. [Clinical Trial, Phase I Clinical Trial, Phase II Research Support, N I H, Extramural Research Support, Non-U S Gov\u2019t]. Cancer Cell 31(4):487\u2013500","journal-title":"Cancer Cell"},{"issue":"2","key":"10313_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1515\/revneuro-2020-0062","volume":"32","author":"H Seyedmirzaei","year":"2021","unstructured":"Seyedmirzaei H, Shobeiri P, Turgut M, Hanaei S, Rezaei N (2021) VEGF levels in patients with glioma: a systematic review and meta-analysis. Rev Neurosci 32(2):191\u2013202. https:\/\/doi.org\/10.1515\/revneuro-2020-0062","journal-title":"Rev Neurosci"},{"issue":"1","key":"10313_CR50","first-page":"vdad009","volume":"5","author":"P Sharma","year":"2023","unstructured":"Sharma P, Aaroe A, Liang J, Puduvalli VK (2023) Tumor microenvironment in glioblastoma: Current and emerging concepts. [Review]. Neurooncol Adv 5(1):vdad009","journal-title":"Neurooncol Adv"},{"issue":"6","key":"10313_CR51","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.freeradbiomed.2006.11.032","volume":"42","author":"PS Smith","year":"2007","unstructured":"Smith PS, Zhao W, Spitz DR, Robbins ME (2007) Inhibiting catalase activity sensitizes 36B10 rat glioma cells to oxidative stress. Free Radic Biol Med 42(6):787\u2013797","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"10313_CR52","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. [Clinical Trial Clinical Trial, Phase III Multicenter Study Randomized Controlled Trial Research Support, Non-U S Gov\u2019t Research Support, U S Gov\u2019t, P H S]. N Engl J Med 352(10):987\u2013996","journal-title":"N Engl J Med"},{"issue":"5","key":"10313_CR53","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Mirimanoff RO (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459\u2013466","journal-title":"Lancet Oncol"},{"key":"10313_CR54","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6570808","author":"P Sun","year":"2017","unstructured":"Sun P, Chen C, Xia Y, Bi X, Liu P, Zhang F, Wang F (2017) The ratio of C-reactive protein\/albumin is a novel inflammatory predictor of overall survival in cisplatin-based treated patients with metastatic nasopharyngeal carcinoma. Dis Markers. https:\/\/doi.org\/10.1155\/2017\/6570808","journal-title":"Dis Markers"},{"key":"10313_CR55","unstructured":"Tamimi AF, Juweid M (2017) Epidemiology and outcome of glioblastoma"},{"issue":"3","key":"10313_CR56","first-page":"3295","volume":"3","author":"J-N Tang","year":"2018","unstructured":"Tang J-N, Goyal H, Yu S, Luo H (2018) Prognostic value of systemic immune-inflammation index (SII) in cancers: a systematic review and meta-analysis. Journal of Laboratory and Precision Medicine 3(3):3295\u20133302","journal-title":"Journal of Laboratory and Precision Medicine"},{"key":"10313_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1355242","volume":"15","author":"DK Tripathy","year":"2024","unstructured":"Tripathy DK, Panda LP, Biswal S, Barhwal K (2024) Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches. Front Pharmacol 15:1355242","journal-title":"Front Pharmacol"},{"key":"10313_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.703761","volume":"12","author":"MS Uddin","year":"2021","unstructured":"Uddin MS, Kabir MT, Mamun AA, Sarwar MS, Nasrin F, Emran TB, Abdel-Daim MM (2021) Natural small molecules targeting NF-\u03baB signaling in glioblastoma. Front Pharmacol 12:703761","journal-title":"Front Pharmacol"},{"issue":"Suppl 1","key":"10313_CR59","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.4103\/ijpm.ijpm_1081_21","volume":"65","author":"MA Vizcaino","year":"2022","unstructured":"Vizcaino MA, Raghunathan A (2022) Evaluating neurosurgical biopsies for CNS tumor diagnoses: An algorithmic and pattern based approach. Indian J Pathol Microbiol 65(Suppl 1):S99\u2013S110. https:\/\/doi.org\/10.4103\/ijpm.ijpm_1081_21","journal-title":"Indian J Pathol Microbiol"},{"issue":"7","key":"10313_CR60","first-page":"1529","volume":"13","author":"S Wang","year":"2020","unstructured":"Wang S, He Q, Zhang Q, Guan B, Zhou X (2020) Clinicopathologic features and prognosis of epithelioid glioblastoma. Int J Clin Exp Pathol 13(7):1529\u20131539","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"10313_CR61","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.7150\/thno.56747","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang Y, Qi H, Liu Y, Duan C, Liu X, Xia T, Liu HX (2021) The double-edged roles of ROS in cancer prevention and therapy. [Research Support, Non-U S Gov\u2019t Review]. Theranostics 11(10):4839\u20134857","journal-title":"Theranostics"},{"issue":"10","key":"10313_CR62","first-page":"1073","volume":"13","author":"PY Wen","year":"2025","unstructured":"Wen PY, Weller M, Lee EQ, Touat M, Khasraw M, Rahman R, Preusser M (2025) Glioblastoma in adults: a society for neuro-oncology (SNO) and European society of neuro-oncology (EANO) consensus review on current management and future directions. Neuro Oncol 13(10):1073\u20131113","journal-title":"Neuro Oncol"},{"issue":"2","key":"10313_CR63","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/0006-2944(76)90049-1","volume":"15","author":"K Yagi","year":"1976","unstructured":"Yagi K (1976) A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 15(2):212\u2013216. https:\/\/doi.org\/10.1016\/0006-2944(76)90049-1","journal-title":"Biochem Med"},{"issue":"473","key":"10313_CR64","doi-asserted-by":"publisher","first-page":"eaao5253","DOI":"10.1126\/scitranslmed.aao5253","volume":"11","author":"W Yang","year":"2019","unstructured":"Yang W, Warrington NM, Taylor SJ, Whitmire P, Carrasco E, Singleton KW, Rubin JB (2019) Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data. [Research Support, N I H, Extramural Research Support, Non-U S Gov\u2019t]. Sci Transl Med 11(473):eaao5253","journal-title":"Sci Transl Med"},{"issue":"16","key":"10313_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25168885","volume":"25","author":"A Zaher","year":"2024","unstructured":"Zaher A, Petronek MS, Allen BG, Mapuskar KA (2024) Balanced duality: H2O2-based therapy in cancer and its protective effects on non-malignant tissues. Int J Mol Sci 25(16):8885","journal-title":"Int J Mol Sci"},{"key":"10313_CR66","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.2147\/OTT.S249317","volume":"13","author":"Y Zeng","year":"2020","unstructured":"Zeng Y, Zhu X, Wang Y, Liu B, Yang X, Wang Q, Guo QN (2020) Clinicopathological, immunohistochemical and molecular genetic study on epithelioid glioblastoma: a series of fifteen cases with literature review. Onco Targets Ther 13:3943\u20133952","journal-title":"Onco Targets Ther"},{"issue":"1","key":"10313_CR67","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1515\/biol-2022-0023","volume":"17","author":"X Zhu","year":"2022","unstructured":"Zhu X, Shi G, Lu J, Qian X, Wang D (2022) Potential regulatory mechanism of TNF-\u03b1\/TNFR1\/ANXA1 in glioma cells and its role in glioma cell proliferation. Open Life Sci 17(1):208\u2013220","journal-title":"Open Life Sci"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-026-10313-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11481-026-10313-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-026-10313-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:02:29Z","timestamp":1787212949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11481-026-10313-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10313"],"URL":"https:\/\/doi.org\/10.1007\/s11481-026-10313-x","relation":{},"ISSN":["1557-1904"],"issn-type":[{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval was obtained from the Ethics and Deontology Committee at the National Health Security Agency \u2018\u2019The Approval Committee\u2019\u2019. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics Approval and Research involving Human Participants","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":4,"name":"Ethics","label":"Competing Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","label":"Conflicts of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"40"}}